Marco Sborgia

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

Uwe Platzbecker, Giuseppe Avvisati, Laura Cicconi et al. · Journal of Clinical Oncology · 2016 · 392 citations · Full text

Medicine, Hematology, Oncology +12

Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype

Enrico Tiacci, Antony B. Holmes, Alexander Kohlmann et al. · Blood · 2011 · 268 citations · Full text

Life Sciences, Genetics, Oncology +14

High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial

R. Willemze, Stefan Suciu, Giovanna Meloni et al. · Journal of Clinical Oncology · 2013 · 168 citations · Full text

Medicine, Oncology, Pharmacology +17

PML–RARα kinetics and impact of FLT3–ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy

Laura Cicconi, Mariadomenica Divona, Claudia Ciardi et al. · Leukemia · 2016 · 82 citations · Full text

Medicine, Hematology, Oncology +13

Liposomal daunorubicin <i>versus</i> standard daunorubicin: long term follow‐up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia

Roberto Latagliata, Massimo Breccia, Paola Fazi et al. · British Journal of Haematology · 2008 · 54 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14